Xenon Pharmaceuticals posts loss of $3.9 million in fourth quarter

BURNABY, B.C. – BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a fourth-quarter loss of $3.9 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 27 cents.

The gene therapy biotech company posted revenue of $3.2 million in the period.

For the year, the company reported a loss of $15.8 million, or $1.10 per share, swinging to a loss in the period. Revenue was reported as $15.6 million.

Xenon Pharmaceuticals shares have declined almost 9 per cent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.33, a decline of 61 per cent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at http://www.zacks.com/ap/XENE

_____

Keywords: Xenon Pharmaceuticals, Earnings Report

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles